| 1 |
<table width="100%" border="0" cellspacing="0" cellpadding="0"> |
| 2 |
<tr> |
| 3 |
<td height="114"> |
| 4 |
<table border="1" cellspacing="0" cellpadding="3" align="center" bordercolor="#283880"> |
| 5 |
<tr> |
| 6 |
<td><img src="p/pic_kastel.gif" width="300" height="131"></td> |
| 7 |
</tr> |
| 8 |
</table> |
| 9 |
</td> |
| 10 |
</tr> |
| 11 |
<tr> |
| 12 |
<td height="405"> |
| 13 |
<p align=center> </p> |
| 14 |
<ul> |
| 15 |
|
| 16 |
|
| 17 |
|
| 18 |
<li><font face="Arial, Helvetica, sans-serif" color="#000080"><small><strong>1921</strong> |
| 19 |
Kastel d.d. is founded</small></font> |
| 20 |
<li><font face="Arial, Helvetica, sans-serif" color="#000080"><small><strong>1928</strong> |
| 21 |
Kastel d.d. moves to Zagreb</small></font> |
| 22 |
<li><font face="Arial, Helvetica, sans-serif"><small><font |
| 23 |
color=#000080><strong>1936</strong> the company becomes one of the first |
| 24 |
global sulfonamide producers</font></small> |
| 25 |
</font> |
| 26 |
<li><font face="Arial, Helvetica, sans-serif"><small><font |
| 27 |
color=#000080><strong>1940</strong> Plibah-Bannat Institute for production |
| 28 |
of biological and chemical medicines</font></small> |
| 29 |
</font> |
| 30 |
<li><font face="Arial, Helvetica, sans-serif" color="#000080"><small><strong>1941</strong> |
| 31 |
Plibah become PLIVA-State Institute for Production |
| 32 |
of Medicines & Vaccines</small></font> |
| 33 |
<li><font face="Arial, Helvetica, sans-serif" color="#000080"><small><strong>1952</strong> |
| 34 |
PLIVA Research Institute is founded</small></font> |
| 35 |
<li><font face="Arial, Helvetica, sans-serif"><small><font |
| 36 |
color=#000080><strong>1953</strong> the first quantities of Vitamin C |
| 37 |
are manufactured using in-house technology</font></small> |
| 38 |
</font> |
| 39 |
<li><font face="Arial, Helvetica, sans-serif"><small><font |
| 40 |
color=#000080><strong>1959</strong> production of Vitamin B and oxytetracycline |
| 41 |
is begun</font></small> </font> |
| 42 |
<li><font face="Arial, Helvetica, sans-serif"><small><font |
| 43 |
color=#000080><strong>1971</strong> methacycline is patented</font></small> |
| 44 |
</font> |
| 45 |
<li><font face="Arial, Helvetica, sans-serif" color="#000080"><small><strong>1980</strong> |
| 46 |
PLIVAs original macrolide antibiotic-azithromycin |
| 47 |
is patented and protected</small></font> |
| 48 |
<li><font face="Arial, Helvetica, sans-serif" color="#000080"><small><strong>1986</strong> |
| 49 |
PLIVA signs a licensing agreement with US company |
| 50 |
Pfizer, granting Pfizer an exclusive right for |
| 51 |
the sale of azithromycin in the USA and western |
| 52 |
Europe</small></font> |
| 53 |
<li><font face="Arial, Helvetica, sans-serif" color="#000080"><small><strong>1988</strong> |
| 54 |
PLIVA launched azithromycin under the name of |
| 55 |
Sumamed</small></font> |
| 56 |
<li><font face="Arial, Helvetica, sans-serif"><small><font |
| 57 |
color=#000080><strong>1991</strong> Pfizer launched azithromycin under |
| 58 |
the name of Zithromax</font></small> </font> |
| 59 |
<li><font face="Arial, Helvetica, sans-serif" color="#000080"><small><b>1991</b> |
| 60 |
Croatia becomes an independent state and <b>PLIVA</b> |
| 61 |
begins its privatization process</small></font> |
| 62 |
<li><font face="Arial, Helvetica, sans-serif" color="#000080"><b><small>1993 |
| 63 |
PLIVA</small></b><small> becomes a joint stock |
| 64 |
company</small></font> |
| 65 |
<li><font face="Arial, Helvetica, sans-serif" color="#000080"><small><b>1996 |
| 66 |
</b>The listing of <b>PLIVA</b>s shares on |
| 67 |
the London Stock Exchange marks the 75th anniversary |
| 68 |
of <b>PLIVA</b></small></font> |
| 69 |
<li><font face="Arial, Helvetica, sans-serif" color="#000080"><small><b>1997</b> |
| 70 |
Acquisition of<b> </b>majority stake of <b>Polfa |
| 71 |
- Krakow </b>(presently - <b>PLIVA Krakow</b>)</small></font> |
| 72 |
<li><font face="Arial, Helvetica, sans-serif" color="#000080"><small><b>1998 </b> new azithromycin production facility was open</small></font> |
| 73 |
<li><font face="Arial, Helvetica, sans-serif" color="#000080"><small><b>1998 |
| 74 |
</b>Acquisition of Slovak Yeast Producer,<b> |
| 75 |
Fermenta </b></small></font> |
| 76 |
|
| 77 |
<li><font face="Arial, Helvetica, sans-serif" color="#000080"><b><small>1999 |
| 78 |
</small></b><small>Acquisition of FARMACOM, |
| 79 |
of MIXIS GENETICS Ltd., and of LACHEMA (presently |
| 80 |
- <b>PLIVA LACHEMA</b>)</small></font> </li> |
| 81 |
<li><font face="Arial, Helvetica, sans-serif" color="#000080"><b><small>2000 |
| 82 |
</small></b><small>Acquisition of Dominion |
| 83 |
</small></font> </li> |
| 84 |
</ul> |
| 85 |
</td> |
| 86 |
</tr> |
| 87 |
<tr> |
| 88 |
<td> |
| 89 |
<table border="1" cellspacing="0" cellpadding="3" align="center" bordercolor="#283880"> |
| 90 |
<tr> |
| 91 |
<td><img src="p/hist_savskimarof.gif" width="200" height="200"></td> |
| 92 |
</tr> |
| 93 |
</table> |
| 94 |
</td> |
| 95 |
</tr> |
| 96 |
</table> |
Parent Directory
| 
Revision Log